MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groebe, D. R.
Right arrow Articles by Abramson, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groebe, D. R.
Right arrow Articles by Abramson, S. N.

alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors

DR Groebe, JM Dumm, ES Levitan and SN Abramson

Department of Pharmacology, School of Medicine, University of Pittsburgh, Pennsylvania 15261, USA.

Muscle subtypes of the nicotinic acetylcholine receptor contain two acetylcholine binding sites that can be distinguished pharmacologically. The affinities of several alpha-conotoxins for the two acetylcholine binding sites on nicotinic receptors from BC3H1 cells and Torpedo electric organ were investigated. alpha-Conotoxins MI, GI, and SIA each inhibited the binding of 125I-alpha-bungarotoxin to nicotinic acetylcholine receptors on BC3H1 cells with two distinct and independent affinities, which differed by > 10,000-fold. The affinities of alpha-conotoxins SI and SII were significantly lower and the differences in the affinities of each of these toxins for the two sites were < 400-fold. alpha-Conotoxins MI, GI, SIA, and SI had higher affinity for the acetylcholine binding site near the alpha/delta subunit interface of nicotinic receptors from BC3H1 cells. However, when assessed using nicotinic receptors from Torpedo electric organ, alpha-conotoxin MI displayed higher affinity for the acetylcholine binding site near the alpha/gamma subunit interface. These observations suggest that species variations in the sequences of the gamma and delta subunits resulted in a dramatic reversal of the relative affinities of the alpha-conotoxins for each acetylcholine binding site. Some of the practical implications of these observations are discussed.

Volume 48, Issue 1, pp. 105-111, 07/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. W. Teichert, J. Rivier, J. Torres, J. Dykert, C. Miller, and B. M. Olivera
A Uniquely Selective Inhibitor of the Mammalian Fetal Neuromuscular Nicotinic Acetylcholine Receptor
J. Neurosci., January 19, 2005; 25(3): 732 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Azam, C. Dowell, M. Watkins, J. A. Stitzel, B. M. Olivera, and J. M. McIntosh
{alpha}-Conotoxin BuIA, a Novel Peptide from Conus bullatus, Distinguishes among Neuronal Nicotinic Acetylcholine Receptors
J. Biol. Chem., January 7, 2005; 280(1): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Antil, D. Servent, and A. Menez
Variability among the Sites by Which Curaremimetic Toxins Bind to Torpedo Acetylcholine Receptor, as Revealed by Identification of the Functional Residues of alpha -Cobratoxin
J. Biol. Chem., December 3, 1999; 274(49): 34851 - 34858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Loughnan, T. Bond, A. Atkins, J. Cuevas, D. J. Adams, N. M. Broxton, B. G. Livett, J. G. Down, A. Jones, P. F. Alewood, et al.
alpha -Conotoxin EpI, a Novel Sulfated Peptide from Conus episcopatus That Selectively Targets Neuronal Nicotinic Acetylcholine Receptors
J. Biol. Chem., June 19, 1998; 273(25): 15667 - 15674.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Sugiyama, P. Marchot, C. Kawanishi, H. Osaka, B. Molles, S. M. Sine, and P. Taylor
Residues at the Subunit Interfaces of the Nicotinic Acetylcholine Receptor That Contribute to alpha -Conotoxin M1 Binding
Mol. Pharmacol., April 1, 1998; 53(4): 787 - 794.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Jacobsen, D. Yoshikami, M. Ellison, J. Martinez, W. R. Gray, G. E. Cartier, K.-J. Shon, D. R. Groebe, S. N. Abramson, B. M. Olivera, et al.
Differential Targeting of Nicotinic Acetylcholine Receptors by Novel alpha A-Conotoxins
J. Biol. Chem., September 5, 1997; 272(36): 22531 - 22537.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. Kulak, T. A. Nguyen, B. M. Olivera, and J. M. McIntosh
alpha -Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
J. Neurosci., July 15, 1997; 17(14): 5263 - 5270.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. X. Albuquerque, M. Alkondon, E. F. R. Pereira, N. G. Castro, A. Schrattenholz, C. T. F. Barbosa, R. Bonfante-Cabarcas, Y. Aracava, H. M. Eisenberg, and A. Maelicke
Properties of Neuronal Nicotinic Acetylcholine Receptors: Pharmacological Characterization and Modulation of Synaptic Function,
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1117 - 1136.
[Full Text]


Home page
J. Biol. Chem.Home page
G. E. Cartier, D. Yoshikami, W. R. Gray, S. Luo, B. M. Olivera, and J. M. McIntosh
A New alpha-Conotoxin Which Targets alpha3beta2 Nicotinic Acetylcholine Receptors
J. Biol. Chem., March 29, 1996; 271(13): 7522 - 7528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. L. Papineni, J. U. Sanchez, K. Baksi, I. U. Willcockson, and S. E. Pedersen
Site-specific Charge Interactions of alpha -Conotoxin MI with the Nicotinic Acetylcholine Receptor
J. Biol. Chem., June 22, 2001; 276(26): 23589 - 23598.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics